Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States

PURPOSE: There are no nationally representative data on oncologists’ use of next-generation sequencing (NGS) testing in practice. The purpose of this study was to investigate how oncologists in the United States use NGS tests to evaluate patients with cancer and to inform treatment recommendations....

Descripción completa

Detalles Bibliográficos
Autores principales: Freedman, Andrew N., Klabunde, Carrie N., Wiant, Kristine, Enewold, Lindsey, Gray, Stacy W., Filipski, Kelly K., Keating, Nancy L., Leonard, Debra G.B., Lively, Tracy, McNeel, Timothy S., Minasian, Lori, Potosky, Arnold L., Rivera, Donna R., Schilsky, Richard L., Schrag, Deborah, Simonds, Naoko I., Sineshaw, Helmneh M., Struewing, Jeffery P., Willis, Gordon, de Moor, Janet S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797241/
https://www.ncbi.nlm.nih.gov/pubmed/35135159
http://dx.doi.org/10.1200/PO.18.00169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797241/
https://www.ncbi.nlm.nih.gov/pubmed/35135159
http://dx.doi.org/10.1200/PO.18.00169

Ejemplares similares